Chad Ritch

9PUBLICATIONS
44CO-AUTHORS
Medical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 06, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial.

|Feb 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Ankur Malpani, Jonathan T Ryan, Hui Yu

|Dec 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.

John L Gore, Erika M Wolff, Michael G Nash

|Oct 17, 2025
4K density: Adjusting the 4Kscore for prostate volume to improve risk stratification of clinically significant prostate cancer in men undergoing prostate biopsy.

Timothy Guerard, Joao G Porto, Thomas Fekete

|Oct 07, 2025
Racial and ethnic differences in valuation of life expectancy in prostate cancer treatment decision making.

John M Masterson, Renning Zheng, Michael Luu

|Aug 19, 2024
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy.

Tarek Ajami, Sunwoo Han, Ruben Blachman-Braun

Pageof 2

Frequent Collaborators

2 joint publications

Sanoj Punnen

2 joint publications

Tarek Ajami

2 joint publications

Archan Khandekar

2 joint publications

Jonathan T Ryan